A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 346-354

  Bantick, R Alexander ^a   Montgomery, Andrew J ^a   Bench, Christopher J ^a   Choudhry, Tariq ^b   Malek, Nina ^c   McKenna, Peter J ^c   Quested, Digby J ^d   Deakin, J F William ^e   Grasby, Paul M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Southall/Norwood Hospital ^*  (United Kingdom)

^c FULBOURN HOSPITAL   (United Kingdom)

^d WARNEFORD HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 HT 1 receptor agonist; 5 HT1A receptor; Clozapine; Emission computed tomography; Schizophrenia; WAY 100635

Indexed keywords

CLOZAPINE; FLUPENTIXOL DECANOATE; HALOPERIDOL; HALOPERIDOL DECANOATE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OLANZAPINE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SULPIRIDE; TRACER; UNCLASSIFIED DRUG; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX; CEREBELLUM VERMIS; CLINICAL ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BINDING; FRONTAL CORTEX; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 6344288788     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800304     Document Type: Article

References (69)

1. Andree B, Hedman A, Thorberg S O, Nilsson D, Halldin C, Farde L (2003) Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain. Psychopharmacology (Berl) 167: 37-45
2. 1A receptors. J Neural Transm 106: 75-105
3. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14: 35-46
4. 1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15: 37-46
5. Burnet P W, Chen C P, McGowan S, Franklin M, Harrison P J (1996a) The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73: 531-540
6. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15: 442-455
7. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30: 565-574
8. 2A receptor mRNA in human brain. Brain Res 676: 157-68
9. 1A receptors by clozapine in the primate brain: a PET study. Psychopharmacology (Berl) 166: 234-240
10. Deakin J F, Simpson M D (1997) A two-process theory of schizophrenia: evidence from studies in post-mortem brain. J Psychiatr Res 31: 277-295
11. 4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia. Neurochem Int 34: 109-115
12. Drevets W C, Frank E, Price J C, Kupfer D J, Greer P J, Mathis C (2000) Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27: 499-507
13. 1A receptors in the primate brain. Psychopharmacology (Berl) 133: 196-202
14. First M B, Spitzer R L, Gibbon M, Williams J B W (1997) Structured Clinical Interview for DSM-IV Axis I Disorders: Clinician version. American Psychiatric Press, Biometrics Research Department, New York State Psychiatric Institute, New York
15. Flanagan R J, Yusufi B, Barnes T R E (2003) Comparability of whole blood and plasma clozapine and norclozapine. Br J Clin Pharmacol 56: 135-138
16. Goff D C, Midha K K, Brotman A W, McCormick S, Waites M, Amico E T (1991) An open trial of buspirone added to neuroleptics in schizophrenic patients. J Clin Psychopharmacol 11: 193-197
17. 1A receptors in rat brain membranes. Eur J Pharmacol 288: 173-186
18. Gunn R N, Lammertsma A A, Hume S P, Cunningham V J (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6: 279-287
19. 11C]WAY-100635 for PET. Neuroimage 8: 426-440
20. 11C]WAY-100635 PET studies. Nucl Med Biol 27: 477-482
21. Gurevich E V, Joyce J N (1997) Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol Psychiatry 42: 529-545
22. Hagino Y, Watanabe M (2002) Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors. Can J Physiol Pharmacol 80: 1158-1166
23. 11C]WAY-100635. Brain Res 745: 96-108
24. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48: 355-363
25. 2 receptor binding in patients with chronic schizophrenia. Psychopharmacology (Berl) 112: S35-S39
26. 1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41: 150-159
27. Ichikawa J, Kuroki T, Dai J, Meltzer H Y (1998) Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. Eur J Pharmacol 351: 163-171
28. 1A receptor. Eur J Pharmacol 441: 137-140
29. Joyce J N, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman J E (1993) Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8: 315-336
30. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156: 286-293
31. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedeberg's Arch Pharmacol 363: 620-632
32. Kronig M H, Munne R A, Szymanski S, Safferman A Z, Pollack S, Cooper T, Kane J M, Lieberman J A (1995) Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Am J Psychiatry 152: 179-182
33. 11C]WAY-100635 [abstract]. Neuroimage 16: S106
34. 11C]WAY- 100635: effect of endogenous serotonin. Synapse 40: 122-129
35. 1A receptors in human brain tissue. Eur J Pharmacol 227: 397-398
36. 11C-carboxylation of an immobilised Grignard reagent. J Labelled Compounds Radiopharm 38: 941-953
37. Meyer J H, Gunn R N, Myers R, Grasby P M (1999) Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage 9: 545-553
38. 1A receptors. J Pharmacol Exp Ther 295: 853-861
39. Miller D D, Fleming F, Holman T L, Perry P J (1994) Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. J Clin Psychiatry 55 (Suppl B): 117-121
40. Mongeau R, Welner S A, Quirion R, Suranyi-Cadotte B E (1992) Further evidence for differential affinity states of the serotonin1A receptor in rat hippocampus. Brain Res 590: 229-238
41. 1A receptor examined using positron emission tomography and neuroendocrine response. Psychopharmacology (Berl) 165: 37-42
42. 1A receptors. Neuropharmacology 35: 119-121
43. 35S]GTPγS binding study. Eur J Pharmacol 355: 245-256
44. A receptor binding in panic disorder. J Neurosci 24: 589-591
45. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 152: 1444-1449
46. 11C]WAY-100635 binding: considerations on the cerebellum. Nucl Med Biol 27: 483-486
47. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab 20: 1111-1133
48. 18F]MPPF. Psychopharmacology (Berl) 155: 193-197
49. Pazos A, Probst A, Palacios J M (1987) Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21: 97-122
50. Perry P J, Miller D D, Arndt S V, Cadoret R J (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 148: 231-235
51. 11C]WAY-100635. Eur J Pharmacol 301: R5-R7
52. 1A receptors in vivo and in vitro: implications for antidepressant therapy. Neuropsychopharmacology 23: 285-293
53. 11C]raclopride. J Psychopharmacol 16: 195-199
54. 1A receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 15: 620-632
55. 11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl) -N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans. J Pharmacol Exp Ther 301: 1144-1150
56. 11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174-180
57. 1A receptor system: possible implications for schizophrenic negative symptomoatology. Psychiatr Annals 26: 88-92
58. 18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans. Synapse 25: 147-154
59. 3H]8-OH-DPAT reveals increases in 5-HT (1A) receptors in ventral prefrontal cortex in schizophrenia. Biol Psychiatry 39: 919-928
60. Sirota P, Epstein B, Benatov R, Sousnostzky M, Kindler S (2001) An open study of buspirone augmentation of neuroleptics in patients with schizophrenia. J Clin Psychopharmacol 21: 454-455
61. Slater P, Doyle C A, Deakin J F (1998) Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates. J Neural Transm 105: 305-315
62. 11C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. Nucl Med Biol 27: 487-492
63. Spina E, Avenoso A, Facciola G, Scordo M G, Ancione M, Madia A G, Ventimiglia A, Perucca E (2000) Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Psychopharmacology (Berl) 148: 83-89
64. Spinks T J, Jones T, Bailey D L, Townsend D W, Grootoonk S, Bloomfield P M, Gilardi M C, Casey M E, Sipe B, Reed J (1992) Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 37: 1637-1655
65. 3H]5- carboxamidotryptamine. Neuropharmacology 37: 1611-1619
66. Studholme C, Hill D L, Hawkes D J (1997) Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys 24: 25-35
67. 1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708: 209-214
68. Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer H Y (2001) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158: 1722-1725
69. 11C]WAY-100635. Arch Gen Psychiatry 59: 514-520